ZeCardio Therapeutics (private company)

See something wrong or missing? Let us know

Offices:Barcelona

Business model:B2B

ZeCardio Therapeutics is a spinoff of ZeClinics based on a technology for a disruptive cardiovascular analysis platform for zebrafish larvae

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Name		Criteria
	Cornea Project 58%	Similar verticals: Biotech, Health services Similar business models: B2B At least one other investor: Capital Cell Total raised in a similar range: < 1M USD
	Aquilón CyL 48%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD
	Bionomous 48%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD
	Causalus 48%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD
	Cebiotex 48%	Similar verticals: Biotech, Health services Similar business models: B2B At least one other investor: Capital Cell
	Celluminova 48%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD
	Emulseo 48%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD
	FinnAdvance 48%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD
	Ikan Biotech 48%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD
	iLoF 48%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD